Pegfilgrastim biosimilar (Kexing Biopharmaceutical)

培非格司亭生物类似药 (科兴生物制药)

Report date: 2025/02/28 16:17:13

Base Information

Drug NamePegfilgrastim biosimilar (Kexing Biopharmaceutical)
Drug Alias NamePolyethylene Glycolized Human Granulocyte Stimulating FactorPEG-G-CSF
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsChemotherapy-Induced Febrile NeutropeniaBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShandong Kexing Bio-Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Kexing Bio-Products Co Ltd
Inactive CompaniesN/A
Active IndicationsChemotherapy-Induced Febrile NeutropeniaBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A